Advanced search
Publication Cover
mAbs Volume 9, 2017 - Issue 5
Submit an article Journal homepage
2,722
Views
20
CrossRef citations to date
0
Altmetric
Report

Infliximab crystal structures reveal insights into self-association

Thomas F. LerchAnalytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, USACorrespondence[email protected]
,
Penelope SharpeAnalytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., Andover, MA, USA
,
Stephen J. MayclinBeryllium Discovery Corp, Bainbridge Island, WA, USAORCID Iconhttp://orcid.org/0000-0002-1600-4554
ORCID Icon,
Thomas E. EdwardsBeryllium Discovery Corp, Bainbridge Island, WA, USA
,
Eunhee LeeAnalytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., Andover, MA, USAORCID Iconhttp://orcid.org/0000-0002-5551-2092
ORCID Icon,
Hugh D. ConlonAnalytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., Andover, MA, USA
,
Sharon PolleckAnalytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., Andover, MA, USA
,
Jason C. RouseAnalytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., Andover, MA, USA
,
Yin LuoAnalytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., Andover, MA, USA
&
Qin ZouAnalytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, USA
 show all
Pages 874-883 | Received 22 Feb 2017, Accepted 13 Apr 2017, Published online: 25 May 2017

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Coline Sivelle, Raphaël Sierocki, Kelly Ferreira-Pinto, Stéphanie Simon, Bernard Maillere & Hervé Nozach. (2018) Fab is the most efficient format to express functional antibodies by yeast surface display. mAbs 10:5, pages 720-729.
Read now

Articles from other publishers (19)

Myriam Nabhan, Sylvain Meunier, Victor Le Minh, Baptiste Robin, Marie de Bourayne, Claire Smadja, Bernard Maillère, Marc Pallardy & Isabelle Turbica. (2023) Infliximab aggregated produced in severe and mild elevated temperature stress conditions induce an extended specific CD4 T-cell response. European Journal of Pharmaceutical Sciences, pages 106670.
Crossref
Marthe Kirkesæther Brun, Kristin Hammersbøen Bjørlykke, Marte K. Viken, Grethe‐Elisabeth Stenvik, Rolf A. Klaasen, Johanna E. Gehin, David John Warren, Joseph Sexton, Øystein Sandanger, Tore K. Kvien, Cato Mørk, Espen A. Haavardsholm, Jørgen Jahnsen, Guro Løvik Goll, Benedicte A. Lie, Nils Bolstad, Kristin Kaasen Jørgensen & Silje Watterdal Syversen. (2023) HLA‐DQ2 is associated with anti‐drug antibody formation to infliximab in patients with immune‐mediated inflammatory diseases. Journal of Internal Medicine 293:5, pages 648-655.
Crossref
Andrea Casasola-LaMacchia, Robert Joseph Seward, Sophie Tourdot, Matthew Willetts, Gary Kruppa, Michael J. Agostino, Gabrielle Bergeron, Nathalie Ahyi-Amendah, Andrew Ciarla, Zhaojiang Lu, Hai-Young Kim, Timothy P. Hickling & Hendrik Neubert. (2022) HLAII peptide presentation of infliximab increases when complexed with TNF. Frontiers in Immunology 13.
Crossref
Xiaobin Xu, Aming Zhang, Yingjie Xu, Yuan Cao, Stephen Cale, Matthew Franklin, Prasad Sarangapani, Peter M. Ihnat, Haibo Qiu, Dingjiang Liu, Erica A. Pyles, Mohammed Shameem & Ning Li. (2022) Deciphering the High Viscosity of a Therapeutic Monoclonal Antibody in High Concentration Formulations by Microdialysis-Hydrogen/Deuterium Exchange Mass Spectrometry. Journal of Pharmaceutical Sciences 111:5, pages 1335-1345.
Crossref
Martin Domnowski, Takahiro Maruno, Kanta Enomoto, Felix Kummer, Alina Kulakova, Pernille Harris, Susumu Uchiyama, Jan Jaehrling & Wolfgang Friess. (2021) A Multi-Method Approach to Assess the Self-Interaction Behavior of Infliximab. Journal of Pharmaceutical Sciences 110:5, pages 1979-1988.
Crossref
Martin Domnowski, Ken Lo Presti, Jonas Binder, Josef Reindl, Lucille Lehmann, Felix Kummer, Meike Wolber, Marion Satzger, Marco Dehling, Jan Jaehrling & Wolfgang Frieß. (2020) Generation of mAb Variants with Less Attractive Self-Interaction but Preserved Target Binding by Well-Directed Mutation. Molecular Pharmaceutics 18:1, pages 236-245.
Crossref
Myriam Nabhan, François-Xavier Legrand, Victor Le-Minh, Baptiste Robin, Rami Bechara, Nicolas Huang, Claire Smadja, Marc Pallardy & Isabelle Turbica. (2020) The FcγRIIa–Syk Axis Controls Human Dendritic Cell Activation and T Cell Response Induced by Infliximab Aggregates. The Journal of Immunology 205:9, pages 2351-2361.
Crossref
Mouhamad Reslan, Vicki Sifniotis, Esteban Cruz, Zeynep Sumer-Bayraktar, Stuart CordwellProf.Prof. & Veysel Kayser. (2020) Enhancing the stability of adalimumab by engineering additional glycosylation motifs. International Journal of Biological Macromolecules 158, pages 189-196.
Crossref
Dennis Krieg, Carolin Berner, Gerhard Winter & Hristo L. Svilenov. (2020) Biophysical Characterization of Binary Therapeutic Monoclonal Antibody Mixtures. Molecular Pharmaceutics 17:8, pages 2971-2986.
Crossref
Myriam Nabhan, Marc Pallardy & Isabelle Turbica. (2020) Immunogenicity of Bioproducts: Cellular Models to Evaluate the Impact of Therapeutic Antibody Aggregates. Frontiers in Immunology 11.
Crossref
Archana Kumari, Deo Nandan Prasad, Sahil Kumar & Rajesh K. Singh. (2020) Clinical Benefits of Switching from Original Infliximab to its Biosimilar (CT-P13) as a Potential TNF-α Inhibitor. Journal of Exploratory Research in Pharmacology 000:000, pages 1-9.
Crossref
Thomas F. Lerch, Penelope Sharpe, Stephen J. Mayclin, Thomas E. Edwards, Sharon Polleck, Jason C. Rouse, Qin Zou & Hugh D. Conlon. (2019) Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar. BioDrugs 34:1, pages 77-87.
Crossref
Linda Cerofolini, Marco Fragai, Enrico Ravera, Christoph A. Diebolder, Ludovic Renault & Vito Calderone. (2019) Integrative Approaches in Structural Biology: A More Complete Picture from the Combination of Individual Techniques. Biomolecules 9:8, pages 370.
Crossref
Vicki Sifniotis, Esteban Cruz, Barbaros Eroglu & Veysel Kayser. (2019) Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation. Antibodies 8:2, pages 36.
Crossref
Hannah Morgan, Su-Yi Tseng, Yann Gallais, Margret Leineweber, Pascale Buchmann, Sabrina Riccardi, Myriam Nabhan, Jeannette Lo, Zaahira Gani, Natacha Szely, Cornelia S. Zhu, Ming Yang, Andrea Kiessling, Hans-Werner Vohr, Marc Pallardy, Fred Aswad & Isabelle Turbica. (2019) Evaluation of in vitro Assays to Assess the Modulation of Dendritic Cells Functions by Therapeutic Antibodies and Aggregates. Frontiers in Immunology 10.
Crossref
Linda Cerofolini, Stefano Giuntini, Azzurra Carlon, Enrico Ravera, Vito Calderone, Marco Fragai, Giacomo Parigi & Claudio Luchinat. (2019) Characterization of PEGylated Asparaginase: New Opportunities from NMR Analysis of Large PEGylated Therapeutics. Chemistry – A European Journal 25:8, pages 1984-1991.
Crossref
Krzysztof Wycisk, Aneta Tarczewska, Magdalena Kaus-Drobek, Michał Dadlez, Rafał Hołubowicz, Zbigniew Pietras, Andrzej Dziembowski, Michał Taube, Maciej Kozak, Marek Orłowski & Andrzej Ożyhar. (2018) Intrinsically disordered N-terminal domain of the Helicoverpa armigera Ultraspiracle stabilizes the dimeric form via a scorpion-like structure. The Journal of Steroid Biochemistry and Molecular Biology 183, pages 167-183.
Crossref
Paul Emsley & Max Crispin. (2018) Structural analysis of glycoproteins: building N-linked glycans with Coot . Acta Crystallographica Section D Structural Biology 74:4, pages 256-263.
Crossref
Heejin Lim, Sang Lee, Hyun Lee, Jee Lee, Ji Son, Woori Shin & Yong-Seok Heo. (2018) Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis. International Journal of Molecular Sciences 19:3, pages 768.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.